The widely used chemotherapy cisplatin causes permanent hearing loss in 40%–60% of
patients with cancer. One drug, sodium thiosulfate, is approved by the FDA for use in …

Background The aim of this study was to characterize the prevalence of self-reported
adverse health outcomes (AHOs), track changes in AHOs, and examine their impact on …

Background Childhood cancer survivors (CCS) exposed to platinum chemotherapy are at an
increased risk of developing hearing loss and reporting decreased quality of life (QOL). This …

There is an interplay between oncology and mental health, resulting in a high prevalence of
mental disorders among cancer patients. Out of the several interventions developed to target …

Methods: Retrospective cohort study at a tertiary care university hospital. The study group
included consecutive patients over years old treated with cisplatin-based chemotherapy …

Objective: Tinnitus is a common auditory symptom that negatively affects the quality of life of
individuals. This study aimed to determine the validity and reliability of a Turkish version of …

Late effects experienced by cancer survivors often depend on the site of the disease, the
treatment regimen, comorbid conditions, health behaviors, and prevention and/or …

BACKGROUND: Current research recorded hearing loss in 8.5 million Nigerians. Hearing
loss can be prevented and treated. Most individuals in the communities are unaware …